Galera
Discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer. Learn more
Launch date
Employees
Market cap
€3.4m
Enterprise valuation
(€5m) (Public information from Sep 2024)
Share price
$0.079 GRTX
Malvern Pennsylvania (HQ)
Authorizing premium user...